Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of the EyeGility™ Inserter ...
Bausch + Lomb Corporation , a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of the EyeGilitytm Inserter preloaded IOL ...
Zacks Investment Research on MSN
Bausch + Lomb launches EyeGility inserter for enVista IOLs in the US
Bausch + Lomb BLCO recently announced the U.S. launch of the EyeGility Inserter, a preloaded intraocular lens (IOL) delivery ...
Orphia, a voice-based AI agent that can call patients to discuss their upcoming cataract surgery and lens options, will soon ...
This summer, Bausch + Lomb unveiled plans to acquire a dry eye disease treatment from Novartis for up to $2.5 billion. Now, the eye health company has closed the deal. The purchase of XIIDRA, a 5% a ...
Bausch + Lomb announced topline results from its phase 2 study of BL1107 in patients with glaucoma. According to the company, ...
About Bausch Health Cos. Inc. Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results